HIV-Related Tuberculosis Diagnosis and Management

HIV-related tuberculosis represents a major public health challenge, driven by the synergistic interplay between immune suppression and Mycobacterium tuberculosis infection. The depletion of CD4+ T cells in people living with HIV undermines classical cell-mediated immunity, leading to increased susceptibility to both primary tuberculosis and reactivation of latent infection. Diagnosis often requires a combination of clinical evaluation, radiological imaging and microbiological confirmation through sputum microscopy, culture or molecular assays. Immunodiagnostic tools such as interferon-gamma release assays (IGRAs) and tuberculin skin tests may be impaired by low CD4 counts, necessitating alternative biomarkers and adjunctive strategies. Management hinges on prompt initiation of anti-tuberculosis treatment alongside antiretroviral therapy (ART), with attention to drug–drug interactions, toxicity and the risk of immune reconstitution inflammatory syndrome. Preventive therapy for latent tuberculosis infection (LTBI) has become integral to comprehensive care, with regimens tailored to local epidemiology and individual risk factors. Integration of HIV and TB services, adherence support and decentralised care models have demonstrated improvements in treatment completion and survival. Despite progress, gaps remain in accurate identification of high-risk individuals, optimal timing of ART initiation and scalable approaches in resource-limited settings.

Research from Nature Portfolio

Recent studies have leveraged time-series modelling and machine learning to forecast trends in TB/HIV coinfection, improving resource planning and intervention deployment. Classical statistical methods such as ARIMA and exponential smoothing establish baseline incidence and seasonality, while deep learning architectures—particularly bidirectional long short-term memory networks and hybrid convolutional neural network models—capture non-linear dynamics and complex interactions. These approaches have demonstrated superior accuracy in predicting case numbers stratified by demographic factors, offering a data-driven foundation for public health decision-making and targeted prevention strategies.

HIV-Related Tuberculosis Diagnosis and Management publication trend

The graph below shows the total number of articles in hiv-related tuberculosis diagnosis and management across all publications each year (not limited to Nature Index journals).

Technical terms

Latent tuberculosis infection (LTBI): Presence of viable Mycobacterium tuberculosis in the host without clinical or radiological signs of active disease, detectable by immune-based assays.

Interferon-gamma release assay (IGRA): Blood test measuring T-cell release of interferon-γ in response to TB-specific antigens, used to identify latent or active infection.

Antiretroviral therapy (ART): Combination drug regimens that suppress HIV replication, restore immune function and reduce the risk of opportunistic infections.

Long short-term memory (LSTM): A recurrent neural network architecture designed to learn temporal dependencies in sequential data, enhancing prediction of epidemiological trends.

References

1. Discrepancy between Mtb-specific IFN-γ and IgG responses in HIV-positive people with low CD4 counts. EBioMedicine (2023).
2. A comparative analysis of classical and machine learning methods for forecasting TB/HIV co-infection. Scientific Reports (2024).
3. Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study. Viruses (2024).